• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.

作者信息

Bichet D G, Ruel N, Arthus M F, Lonergan M

出版信息

Nephron. 1990;56(4):449-50. doi: 10.1159/000186196.

DOI:10.1159/000186196
PMID:1964202
Abstract
摘要

相似文献

1
Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.咯利普兰，一种磷酸二酯酶抑制剂，用于治疗两名先天性肾性尿崩症男性患者。
Nephron. 1990;56(4):449-50. doi: 10.1159/000186196.
2
Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.肾性尿崩症小鼠尿浓缩功能缺陷的原因。
Physiol Bohemoslov. 1990;39(1):103-11.
3
Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.在患有肾性尿崩症的小鼠中诱导膜内颗粒簇的形成。
Am J Physiol. 1991 Oct;261(4 Pt 2):F640-6. doi: 10.1152/ajprenal.1991.261.4.F640.
4
[Pathogenesis and treatment of congenital nephrogenic diabetes insipidus (author's transl)(proceedings)].先天性肾性尿崩症的发病机制与治疗（作者译文）（会议论文集）
Ann Endocrinol (Paris). 1976 Jul-Aug;37(4):313-4.
5
Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.环磷酸腺苷特异性磷酸二酯酶抑制剂咯利普兰和二丁酰环磷酸腺苷对痤疮丙酸杆菌和脂多糖诱导的小鼠肝炎的保护作用。
Inflamm Res. 1999 Jul;48(7):380-5. doi: 10.1007/s000110050475.
6
Clinical and biochemical effects of the selective phosphodiesterase inhibitor rolipram in depressed inpatients controlled by determination of plasma level.通过测定血浆水平来控制的抑郁症住院患者中，选择性磷酸二酯酶抑制剂咯利普兰的临床和生化效应
Pharmacopsychiatry. 1988 Nov;21(6):378-9. doi: 10.1055/s-2007-1017016.
7
Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.4型磷酸二酯酶抑制剂对小鼠急性肺损伤的抑制作用
Am J Respir Cell Mol Biol. 1998 Mar;18(3):411-20. doi: 10.1165/ajrcmb.18.3.2913.
8
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.环磷酸腺苷系统在小鼠吗啡身体依赖性中的作用：磷酸二酯酶4抑制剂咯利普兰对吗啡依赖性发展的预防作用
Br J Pharmacol. 2001 Mar;132(5):1111-7. doi: 10.1038/sj.bjp.0703912.
9
Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus.环磷酸腺苷磷酸二酯酶同工酶在小鼠肾性尿崩症发病机制中的作用
Am J Physiol. 1991 Aug;261(2 Pt 2):F345-53. doi: 10.1152/ajprenal.1991.261.2.F345.
10
Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.IV型磷酸二酯酶抑制剂对人嗜酸性粒细胞呼吸爆发和环磷酸腺苷水解的抑制作用：与β肾上腺素能受体激动剂沙丁胺醇的相互作用
J Pharmacol Exp Ther. 1994 Dec;271(3):1167-74.

引用本文的文献

1
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).先天性肾性尿崩症（精氨酸加压素抵抗）诊断与管理的国际专家共识声明
Nat Rev Nephrol. 2025 Feb;21(2):83-96. doi: 10.1038/s41581-024-00897-z. Epub 2024 Oct 22.
2
Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.靶向肾脏水通道的转运以获得治疗益处。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:175-194. doi: 10.1146/annurev-pharmtox-010919-023654. Epub 2019 Sep 27.
3
Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.
无血管加压素时水通道蛋白2（AQP2）水通道的激活：先天性肾性尿崩症的治疗策略
Clin Exp Nephrol. 2018 Jun;22(3):501-507. doi: 10.1007/s10157-018-1544-8. Epub 2018 Feb 24.
4
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.遗传性肾性尿崩症：病理生理学和可能的治疗。更新。
Int J Mol Sci. 2017 Nov 10;18(11):2385. doi: 10.3390/ijms18112385.
5
Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.罗氟司特与大鼠肾内髓集合管中水通道蛋白-2的调节
Physiol Rep. 2017 Jan;5(2). doi: 10.14814/phy2.13121.
6
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.水通道蛋白-2在肾主细胞中的转运——心血管疾病药物干预的潜在靶点
Front Pharmacol. 2016 Feb 11;7:23. doi: 10.3389/fphar.2016.00023. eCollection 2016.
7
High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration.高通量化学筛选鉴定出 AG-490 是水通道蛋白 2 膜表达和尿液浓缩的刺激剂。
Am J Physiol Cell Physiol. 2014 Oct 1;307(7):C597-605. doi: 10.1152/ajpcell.00154.2014. Epub 2014 Jun 18.
8
Urinary concentration: different ways to open and close the tap.尿液浓缩：打开和关闭水龙头的不同方式。
Pediatr Nephrol. 2014 Aug;29(8):1297-303. doi: 10.1007/s00467-013-2526-4. Epub 2013 Jun 6.
9
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.肾源性尿崩症：对分子背景的基本认识及治疗的潜在疗法。
Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29.
10
New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.肾脏上皮细胞对水和酸碱平衡的动态调节的新认识。
Am J Physiol Cell Physiol. 2012 May 15;302(10):C1421-33. doi: 10.1152/ajpcell.00085.2012. Epub 2012 Mar 28.